Furthermore, eosinophils promote TAM polarization toward anti-tumor M1-like phenotypes via CXCL9 secretion, which recruits CD8 + T cells to bolster immune checkpoint inhibitor (ICI) efficacy. This evidence concerns the gene CXCL9 and neoplasm.